CNMD tops Q1 estimates despite sales dip, lifts 2026 organic growth outlook as strategic shift sharpens focus on ...

Q1 2026 Management View "During the first quarter, we reached an agreement to divest certain GI products. And in April, we reached a second agreement to divest our remaining GI products." (President, ...

Smoke evacuation growth is increasingly driven by direct sales where CONMED controls the customer relationship, intentionally ...

Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results , but sales fell by 1.3% year on year to $317 million. The ...

NEW YORK (Reuters) - Activist investor Voce Capital Management LLC is pushing ConMed Corp (NSQ:CNMD) to pursue a sale, saying it believes the surgical-device maker could attract buyout interest from ...

CONMED Corporation CNMD is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid recurring revenue base and potential in General Surgery ...

CONMED stock draws attention as healthcare technology trends evolve, highlighting company developments, institutional activity, and sector positioning within the broader medical device landscape ...

We think that DENTSPLY stock (NASDAQ NDAQ: XRAY), a dental equipment company, is currently a better pick than ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for ...

CONMED Corporation (NYSE:CNMD) posted better-than-expected earnings for its fourth quarter, but issued FY25 earnings and revenue guidance below estimates. Conmed reported quarterly earnings of $1.34 ...

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less ...

We think that Stryker Corporation currently is a better bet compared to Conmed Corp. CNMD stock trades at 4x trailing revenues, lower than that of SYK, whose P/S multiple stands at 6.1x. Does this gap ...